Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synergistic interaction and platelet inhibitory agonists.

A H Osmani, K A Clare, M C Scrutton

    Thrombosis Research
    |September 1, 1983
    PubMed
    Summary

    Platelet agonists show synergistic interactions primarily in excitatory responses. This interaction appears limited, as inhibitory agonists do not exhibit similar synergistic effects on adenylate cyclase.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationship Between the Systems Responsible for Uptake of 5-hydroxytryptamine and of Noradrenaline by Human Blood Platelets.

    Platelets·2010
    Same author

    Inhibition of Platelet Aggregation by Roussin's Black Salt, Sodium Nitroprusside and Other Metal Nitrosyl Complexes.

    Platelets·2010
    Same author

    Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets.

    Platelets·2010
    Same author

    Release of Choline Metabolites from Human Platelets: Evidence for Activation of Phospholipase D and of Phosphatidylcholine-specific Phospholipase C.

    Platelets·2010
    Same author

    Platelet-Platelet Contact is Required to Observe Guanylate Cyclase Activation in Stimulated Platelets.

    Platelets·2010
    Same author

    Factors affecting the observation of a synergistic response in platelet aggregation induced by pairs of excitatory agonists.

    Platelets·2010

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Cell Signaling

    Background:

    • Platelet activation is crucial for hemostasis and thrombosis.
    • Adenylate cyclase plays a key role in regulating platelet activity.
    • Understanding agonist interactions is vital for developing anti-thrombotic therapies.

    Purpose of the Study:

    • To investigate synergistic interactions between platelet agonists.
    • To determine if synergistic interactions are specific to excitatory or inhibitory pathways.
    • To elucidate the role of adenylate cyclase in agonist synergy.

    Main Methods:

    • Studied the effects of combinations of platelet agonists.
    • Measured adenylate cyclase activity in response to agonists.
    • Differentiated between excitatory and inhibitory agonist actions.

    Main Results:

    • Marked synergistic interaction observed between two platelet excitatory agonists.
    • No synergistic interaction found between platelet inhibitory agonists (PGI2, PGD2, adenosine).
    • ADP and adrenaline showed no synergy when acting as inhibitory agonists for adenylate cyclase.

    Conclusions:

    • Synergistic interaction among platelet agonists appears restricted to excitatory responses.
    • The findings provide insights into the mechanisms of platelet aggregation.
    • Further research may explore targeted therapies based on these synergistic effects.

    Related Experiment Videos